Weekly Recap

Lacosamide Meets Primary End Point, Lemborexant Well-Tolerated in Elders, Cala Trio Reduces Hand Tremor

September 05, 2020

Neurology News Network for the week ending September 5, 2020.

MS Physical Activity Recommendations, FDA Approves Celecoxib, Rituximab Effect on Myasthenia Gravis

May 09, 2020

Neurology News Network for the week ending May 9, 2020.

Neurologic Symtpoms of COVID19, Rimegepant Available Via Telemedicine, Natalizumab

April 18, 2020

Neurology News Network for the week ending April 18, 2020.

Risdiplam PDUFA Pushed Back, Masitinib Gains NDA, COVID19 Affects CNS

April 11, 2020

Neurology News Network for the week ending April 11, 2020.

Teleheath Webinar on COVID-19 Now Available, Coronavirus' Effect on MS Patients, New Mind Moments Podcast

March 21, 2020

Neurology News Network for the week ending March 21, 2020.

FDA Approves Rimegepant, Results on Ofatumumab Trial, Diazepam Becomes Commercially Available

March 07, 2020

Neurology News Network for the week ending March 7, 2020.

Augusto Miravalle, MD: How Cladribine Sets Itself Apart in MS

March 06, 2020

The associate professor in the department of neurology at the University of Colorado and neurologist at Advanced Neurology of Colorado discussed the advantages of cladribine and details of the ongoing CLICK-MS study.

Huntington Disease Trial Results; Mind Moments Podcast Now Live; PMM Trial Falls Short

January 04, 2020

Neurology News Network for the week ending January 4, 2020.

RimabotulinumtoxinB for Sialorrhea, Zogenix Resubmits Fenfluramine NDA, Long-Term Lemborexant Insomnia Data

October 05, 2019

Neurology News Network for the week ending October 5, 2019.

STOP 301 Trial of INP104 Initiated, Suvodirsen Gets Fast Track Designation, Siponimod EXPAND Data

September 21, 2019

Neurology News Network for the week ending September 21, 2019.